Skip to main content

Table 1 Patient characteristics

From: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study

Variable

Frequency (N = 2075)

%

Age (in years)

 < 40

1017

49.0

 40–49

526

25.3

 50–59

321

15.5

 > −60

211

10.2

Median age (IQR), min-max

40 (32–50), 18–98

Sex

 Male

1379

66.5

 Female

696

33.5

Comorbidities (n = 2071a)

 Yes

483

23.3

 No

1588

76.7

Type of comorbidityd

 Hypertension

369

17.8

 Diabetes

150

7.2

 Asthma

42

2.0

 HIV/Hepatitis B

15

0.7

 Other CVS diseases

14

0.6

 Cancer

15

0.7

 Renal disease

10

0.5

 Sickle cell disease

6

0.3

 Tuberculosis & other lung diseases

7

0.3

Symptoms (n = 2071b)

 Asymptomatic to mild

1192

57.6

 Symptomatic beyond mild

879

42.4

Severity on admission (n = 2071c)

 Mild/asymptomatic

1179

56.9

 Moderate

743

35.9

 Severe

107

5.2

 Critical

42

2.0

Discharge status

 Determined

1739

83.8

 Yet undetermined (still on admission)

336

16.2

Discharge status determined (n = 1739)

 Died

73

4.2

 Recovered

1638

98.4

 Transferred out/Evacuated

28

1.6

  1. a Missing = 4(0.2%) bMissing = 4(0.2%) cMissing = 4 (0.2%)
  2. d Multiple comorbidities reported by some patients